CompletedNot applicableNCT03758963
Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy
Studying Central serous chorioretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CynosureLutronic
- Principal Investigator
- Oh Woong Kwon, PhDNune Eye Hospital
- Intervention
- R:GEN Selective Retina Therapy(device)
- Enrollment
- 63 enrolled
- Eligibility
- 19-55 years · All sexes
- Timeline
- 2016 – 2018
Study locations (6)
- Seoul National University Bundang Hospital, Seongnam-si, South Korea
- Korea University Anam hospital, Seoul, South Korea
- Nune Eye Hospital, Seoul, South Korea
- Seoul National University Hospital, Seoul, South Korea
- The Catholic University of Korea Seoul ST.Mary's Hospital, Seoul, South Korea
- The Catholic University of Korea Yeouido St.Mary's Hospital, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03758963 on ClinicalTrials.govOther trials for Central serous chorioretinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06527326the Study of the Association Between the Gut Microbiota and Central Serous ChorioretinopathySecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT06346405Central Serous Chorioretinopathy and Micropulse Laser TreatmentFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNANCT05570591Subthreshold Nanosecond Laser for Non-resolving Central Serous ChorioretinopathyNova Eye Medical Pty Ltd.
- RECRUITINGNCT05589974Choroidal Blood Flow in Acute and Chronic Central Serous ChorioretinopathyHelse Stavanger HF